Navigation Links
Autopulse Would Reduce the Mortality Rates in Rural Victoria

According to a study conducted by Prof Bernard a senior lecturer at Monash University's department of epidemiology and preventative medicine, it was found that more number// of rural people of heart attacks than their counterparts who live in urban areas.

Statistics show that heart disease mortality rates in rural areas are 30 % higher in men and 21 % higher in women than in urban areas. But the solution to this problem cannot be tackled by increasing the number of ambulance services. The main reason being that the population in the rural Victoria is very less and not more than 1000 in a town. Hence the ambulance would do less than one job a week and maintaining an ambulance station would cost about $1 million a year. To help solve the problem AutoPulse was introduced to reduce the number of deaths due to heart attack in the rural areas.

It is a mechanical heart compressor and is found id to more effective than the manual compressors. The ambulance in the rural areas are fitted with these which costs about $20,000 and three were sent to Geelong and two each to Bendigo and Ballarat. The AutoPulse squeezes the patient's entire chest to provide increased blood flow while the paramedics are free to work on supplying oxygen, medication, defibrillation equipment or driving the patient to hospital. The lead author said that AutoPulse would be of great help in those areas where there are fewer paramedics. The study results were published in the Medical journal of Australia.


'"/>




Page: 1

Related medicine news :

1. Patients Pressure Would Result In Overprescription
2. Smallpox Would Spread Rapidly
3. Legalization Of Euthanasia Would Not Affect Patient’s Trus
4. Stem Cell Bank In UK Would Require 150 Embryo-Derived Stem Cell Lines
5. UN Fears Melting Of Ice Would Concentrate Toxins in the Chinese Water Supply
6. Early Detection Of Primary Liver Cancer Would Save Millions Of Lives
7. NHS Trust Would Soon Take On The Hospital Superbug
8. 60 Million People Would Die Due To NCD In India
9. Inactivation of Rad9 in Tumor Cells Would Be Advantageous In Cancer Therapy
10. Small Cars, Anti-AIDS And Anti-Cancer Drugs Would Be Cheaper
11. Study Would Pave Way for the Development of New Drugs That Targets TB Proteasome
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/20/2017)... ... June 20, 2017 , ... AMC Health , the leading provider ... the clinical trials market. Similar to its approach in demonstrating positive outcomes in the ... marketplace by proving the value of eVisits to support virtual studies. , ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... in Cincinnati, OH for leading-edge care, whether or not they have a referral. ... the BIOLASE WaterLase® iPlus™ laser, she targets bacteria and damaged tissue without affecting ...
(Date:6/20/2017)... JEFFERSON HILLS, PA (PRWEB) , ... June 20, ... ... now available at Allegheny Health Network’s (AHN) Jefferson Hospital is providing physicians with ... 1.5T, 48-channel scanner provides higher-resolution images than traditional MRIs, enabling doctors to get ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... SweetLeaf® Stevia Sweetener, Michael P. May, Ph.D., recently accepted the distinguished Sun Corridor ... Program selected Wisdom Natural Brands (WNB), and 16 other businesses from Pima, Pinal, ...
(Date:6/20/2017)... ... 20, 2017 , ... BrightStar Care Centerville/South Dayton, a home ... Joint Commission, which accredits and certifies nearly 21,000 healthcare organizations and programs in ... symbol of quality that reflects an organization’s commitment to meeting certain performance standards. ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... 7, 2017  Novavax, Inc., (Nasdaq: NVAX ) ... 2 trials of its RSV F protein recombinant nanoparticle vaccine ... have been published in the journal Vaccine ... in prior scientific conferences). The Company previously announced top ... is developing the RSV F Vaccine with the goal of ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly ... announced that results from the Phase 3 MONARCH ... (CDK)4 & 6 inhibitor, in combination with fulvestrant, ... with fulvestrant alone in women with hormone-receptor-positive (HR+), ... breast cancer who have relapsed or progressed after ...
(Date:5/30/2017)... May 30, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... Global Healthcare Conference on Tuesday, June 13, 2017, in ... , Hill-Rom,s president and chief executive officer, is scheduled to ... audio webcast can be accessed at http://ir.hill-rom.com/events.cfm . A ... the live event through September 13, 2017. ...
Breaking Medicine Technology: